Current through Vol. 41, No. 13, March 15, 2024
(a) Each person registered or otherwise
authorized to conduct analytical laboratory activites with controlled dangerous
substances shall maintain records with the following information to the extent
known and reasonably ascertainable by him/her for each controlled dangerous
substance:
(1) The name of the
substance.
(2) The form or forms in
which the substance is received, imported, or manufactured by the registrant
(e.g., powder, granulation, tablet, capsule, or solution) and the concentration
of the substance in such form (e.g., C.P., U.S.P., N.D., 10-milligram tablet or
10-milligram concentration per milliliter).
(3) The total number of the forms received,
imported, or manufactured (e.g., 100 tablets, 30 1-milliliter vials, or 10
grams of powder), including the date and quantity of each receipt, importation
or manufacture, and the name, address, and Federal Drug Enforcement
Administration registration number, if any, of the person from whom the
substance was received.
(4) The
quantity distributed or destroyed in any manner by the registrant (except
quantities used in chemical analysis or other laboratory work), including the
date and manner of distribution or destruction and the name, address, and
Federal Drug Enforcement Administration registration number, if any, of each
person to whom the substance was distributed.
(b) Records relating to known or suspected
controlled dangerous substances received as evidentiary material for analysis
are not required under (a) of this Section.
(c) Each person registered to conduct
analytical laboratory activities of samples of suspected controlled dangerous
substances shall maintain records containing the following information (to the
extent known and reasonably ascertainable by him/her):
(1) Laboratory identification number.
(2) Date the sample was received.
(3) Purported contents and actual
identification.
(4) Quantity
received.
(5) Form of sample (i.e.,
powder, liquid, tablets, etc.).
(6)
Description of sample.
(7) Quantity
utilized in analysis.
(8)
Disposition of sample.
(9) Street
price, if known.
(10) Method
shipment is received.
(11) Each
laboratory shall submit to the OBN a quarterly report containing at least the
following information:
(A) Actual content of
drug analyzed.
(B) Alleged content
of drug analyzed.
(C) Description
of sample.
(D) Origin of sample.
(E) Street price, if known.
(d)
Qualitative and quantitative analysis may be conducted of samples.
(1) Security of standards and samples,
including Schedule I medical marijuana, shall be in accordance with
475:20-1-6 and
475:20-1-7, with the exception
that all standards and samples must be treated as Schedules I and II.
(2) Any unused portion of a submitted sample
shall be disposed of in accordance with
475:35-1-4.
(3) All controlled dangerous substances
distributed to drug canine handler registrants and scientific research
registrants shall be analyzed quantitatively, and a record of such analysis
shall be maintained prior to distribution. Oklahoma State Bureau of
Investigation has discretion to refuse to distribute any controlled dangerous
substances. Each such registrant shall receive a copy of the quantitative
analysis.
Amended at 12 Ok Reg 2843,
eff 7-15-95